¹¹¹In-Labeled Cystine-Knot Peptides Based on the Agouti-Related Protein for Targeting Tumor Angiogenesis

Figure 3

U87MG tumor uptake for ¹¹¹In-DOTA-AgRP-7C and ¹¹¹In-DOTA-AgRP-6E at 0.5, 2, and 24 h p.i. (a). Tumor (T)-to-normal organ ratios for ¹¹¹In-DOTA-AgRP-7C with or without c(RGDyK) blocking peptide at 2 h after the injection of the probe (b).

(a)

(b)